Wasserman SI |
Mediators of immediate hypersensitivity. |
1983 |
J. Allergy Clin. Immunol. |
pmid:6193157
|
Swendsen CL et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6407484
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hallam TJ et al. |
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin. |
1983 |
FEBS Lett. |
pmid:6617886
|
Roussi J et al. |
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. |
1983 |
Nouv Rev Fr Hematol |
pmid:6622253
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Benveniste J et al. |
The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. |
1983 |
Br. J. Pharmacol. |
pmid:6652376
|
Garcia Gil M and Sanchez Crespo M |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes. |
1983 |
Immunopharmacology |
pmid:6654649
|
Billah MM and Johnston JM |
Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6407483
|
Chilton FH et al. |
Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6408071
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Gonzalez-Crussi F and Hsueh W |
Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. |
1983 |
Am. J. Pathol. |
pmid:6859226
|
Camussi G et al. |
Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. |
1983 |
Am. J. Pathol. |
pmid:6859232
|
Sánchez-Crespo M et al. |
Presence in normal human urine of a hypotensive and platelet-activating phospholipid. |
1983 |
Am. J. Physiol. |
pmid:6859262
|
Acharya SB and MacIntyre DE |
Platelet products and vascular PGI2 production. |
1983 |
Prostaglandins Leukot Med |
pmid:6338532
|
Camussi G et al. |
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. |
1983 |
Immunology |
pmid:6339375
|
Billah MM and Lapetina EG |
Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation. |
1983 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6341992
|
Lapetina EG and Siegel FL |
Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein. |
1983 |
J. Biol. Chem. |
pmid:6345519
|
Camussi G et al. |
Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit. |
1983 |
Prostaglandins |
pmid:6346397
|